n-acetylneuraminic acid has been researched along with Diabetic Neuropathies in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Crook, MA; Earle, K; Morocutti, A; Pickup, JC; Viberti, G; Yip, J | 1 |
Crook, MA; Ingham, JN; Powrie, JK; Shaw, KM; Taub, NA; Watts, GF | 1 |
Crook, MA; Fuller, JH; Georgino, F; Giorgino, F; Lumb, PJ; Pickup, JC; Webb, DJ | 1 |
3 other study(ies) available for n-acetylneuraminic acid and Diabetic Neuropathies
Article | Year |
---|---|
Serum sialic acid, a risk factor for cardiovascular disease, is increased in IDDM patients with microalbuminuria and clinical proteinuria.
Topics: Adult; Albuminuria; Analysis of Variance; Biomarkers; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Female; Glomerular Filtration Rate; Humans; Male; N-Acetylneuraminic Acid; Proteinuria; Risk Factors; Sialic Acids; Triglycerides | 1994 |
Serum sialic acid and the long-term complications of insulin-dependent diabetes mellitus.
Topics: Adult; Age of Onset; Albuminuria; Biomarkers; Creatinine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Humans; N-Acetylneuraminic Acid; Proteinuria; Sialic Acids | 1996 |
Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study.
Topics: Adult; Albuminuria; Body Constitution; Cholesterol; Coronary Disease; Creatinine; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Exercise; Female; Glycated Hemoglobin; Humans; Hypertension; Logistic Models; Male; N-Acetylneuraminic Acid; Risk Factors; Smoking; Triglycerides | 2001 |